Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > TSM | Tesa purity 99% TSM high purity 99% white powder
TSM | Tesa purity 99% TSM high purity 99% white powder buy - large image1
TSM | Tesa purity 99% TSM high purity 99% white powder buy - image1
TSM | Tesa purity 99% TSM high purity 99% white powder buy - image2
TSM | Tesa purity 99% TSM high purity 99% white powder buy - image3
TSM | Tesa purity 99% TSM high purity 99% white powder buy - image4
TSM | Tesa purity 99% TSM high purity 99% white powder buy - image5

TSM | Tesa purity 99% TSM high purity 99% white powder

COA 6804 Inquiries

Unit Price:

$46/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

hongkong

Packaging:

5mg per vial, 10 vials per box.

Price valid (until):

2027-07-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

PEPTIDES

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Get More Information ,whatsapp: Jocelyn: +86 19900975078



      Product Detail  


    • TSM is an advanced bioactive hydrogel inspired by the wet adhesion properties of mussels. The active ingredients primarily consist of Tannic Acid (TA)Silk Fibroin (SF), and therapeutic agents such as Minocycline Hydrochloride (MCH). Through hydrogen bonding between the amide bonds of SF and the phenolic hydroxyl groups of TA, a stable β-sheet network is formed. The therapeutic agent is then incorporated into this network via dynamic Schiff base reactions under mild aqueous conditions.Shop TSM | Tesa purity 99% TSM high purity 99% white powder-Detailed Image 1

      Its mechanism relies on its exceptional wet-adhesive capability within dynamic fluid environments. Upon application, the hydrogel forms a robust bond with tissue surfaces even in the presence of blood or saliva. This strong adhesion extends the local retention time of the material. Furthermore, the porous structure of the hydrogel allows for the controlled release of therapeutic agents through swelling and diffusion, providing sustained antibacterial and anti-inflammatory effects while maintaining a stable network structure in the body's microenvironment.

      When storing peptides, remember to:
      • Store peptide in a cold, dry, dark place
      • Avoid repeated freezing and thawing of peptide
      • Avoid overexposure to the air
      • Avoid light exposure
      • Avoid storing peptides in solution long term
      • Aliquot peptide according to experimental requirements

      FAQ

      Q: What is the minimum order quantity (MOQ)?
      A: It depends on the product; the standard MOQ is usually 100g, though trial orders of 10g or 20g are available for some products.


      Q: Can you provide samples?
      A: Yes, free samples are available for some products (shipping costs are borne by the customer).


      Q: Are there discounts for bulk orders?
      A: Yes. Please provide the product name, quantity, and destination country, and we will provide an accurate quote.



      Q: How soon will the order ship?
      A: In-stock items usually ship within 1–3 business days after payment confirmation, and tracking information will be provided.



      Q: How long does international shipping take?


      A: Shipping time depends on the destination country and local delivery conditions. Generally, international shipping takes about 5–12 business days.



      Q: What payment methods do you accept?
      A: We accept , Wise, Zelle, USDT, BTC, etc.



      Q: How do I place an order?
      A: Please send us the product name, order quantity, specifications, and destination country; we will then confirm the price, stock availability, and shipping arrangements.


      Shop TSM | Tesa purity 99% TSM high purity 99% white powder-Detailed Image 2
    •  


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    PEPTIDES

    Location:

    Room 305, 3rd Floor, Unit 2, Building 48, Datangxia Zone 2, Choucheng Subdistrict, Yiwu, Jinhua, Zhejiang Province, China

    Year of Establishment:

    2026

  • Inquiry History
    6804 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.